Join
Live feed
·
INSIDERFilingvia Quantisnow
Adamis Pharmaceuticals Corporation logo

SEC Form 4: Benedicto David C. sold $2,208 worth of shares (3,603 units at $0.61) as part of a pre-agreed trading plan, decreasing direct ownership by 8% to 39,875 units to satisfy withholding obligation

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ADMP (Adamis Pharmaceuticals Corporation) and more on Quantisnow.